Status:
COMPLETED
Inhaled Beclomethasone to Prevent Chronic Lung Disease
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Bronchopulmonary Dysplasia
Hyaline Membrane Disease
Eligibility:
All Genders
Up to 1 years
Phase:
PHASE3
Brief Summary
To test if inhaled glucocorticoids, early in the course of respiratory failure in premature infants, permit normal lung growth and differentiation, thus preventing development of bronchopulmonary dysp...
Detailed Description
BACKGROUND: Bronchopulmonary dysplasia (BPD), a fibrotic/emphysematous lung disorder is a common sequela among extremely premature infants. The severity of BPD, but not incidence, has been reduced by...
Eligibility Criteria
Premature boy and girl infants with birth weight less than 1,251 grams, gestational age less than 33 weeks, and postnatal age three to fourteen days, who continue to require mechanical ventilation with an emphasis on enrollment at three days.
Key Trial Info
Start Date :
June 1 1993
Trial Type :
INTERVENTIONAL
End Date :
April 1 1999
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000576
Start Date
June 1 1993
End Date
April 1 1999
Last Update
February 18 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.